Information Provided By: 
Fly News Breaks for June 14, 2017
BIIB, ALXN
Jun 14, 2017 | 07:55 EDT
Credit Suisse analyst Alethia Young said Alexion's (ALXN) poaching of biopharma CFO veteran Paul Clancy from Biogen (BIIB) is a strong hire for the former and a loss for the operations of the latter. She expects Alexion shares to be higher today, and for Biogen to be weak, following the news. Young keeps an Outperform rating on Alexion.
News For ALXN;BIIB From the Last 2 Days
